Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-06-03 Sale |
2025-06-04 6:39 pm |
Editas Medicine Inc. | EDIT | Parison Amy SVP, Chief Financial Officer |
446 | $1.724 | $769 | 17,506 (Direct) |
View |
| 2025-06-03 Sale |
2025-06-04 6:37 pm |
Editas Medicine Inc. | EDIT | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER |
726 | $1.7243 | $1,252 | 69,519 (Direct) |
View |
| 2025-06-03 Sale |
2025-06-04 6:36 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
15,192 | $1.7243 | $26,196 | 280,282 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-05 4:44 pm |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
4,109 | $1.7108 | $7,030 | 112,720 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-05 4:43 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
16,632 | $1.7107 | $28,452 | 295,474 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-05 4:41 pm |
Editas Medicine Inc. | EDIT | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER |
2,891 | $1.7107 | $4,946 | 70,245 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-05 4:40 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
1,618 | $2.0774 | $3,361 | 312,106 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-05 4:37 pm |
Editas Medicine Inc. | EDIT | Mei Baisong EVP, CHIEF MEDICAL OFFICER |
541 | $2.0772 | $1,124 | 133,354 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-06 4:20 pm |
Editas Medicine Inc. | EDIT | Mei Baisong EVP, CHIEF MEDICAL OFFICER |
518 | $3.4247 | $1,774 | 133,895 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-06 4:18 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
1,555 | $3.4247 | $5,325 | 313,724 (Direct) |
View |
| 2024-07-25 Sale |
2024-07-26 5:02 pm |
Editas Medicine Inc. | EDIT | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER |
11,886 | $5.4156 | $64,370 | 73,136 (Direct) |
View |
| 2024-07-19 Sale |
2024-07-22 5:01 pm |
Editas Medicine Inc. | EDIT | Mei Baisong EVP, CHIEF MEDICAL OFFICER |
6,619 | $5.2056 | $34,456 | 134,413 (Direct) |
View |
| 2024-06-04 Sale |
2024-06-06 4:17 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
12,191 | $5.4956 | $66,997 | 315,279 (Direct) |
View |
| 2024-06-04 Sale |
2024-06-06 4:16 pm |
Editas Medicine Inc. | EDIT | Mei Baisong EVP, CHIEF MEDICAL OFFICER |
511 | $5.4956 | $2,808 | 141,032 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 4:30 pm |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
22,337 | $5.6142 | $125,404 | 116,829 (Direct) |
View |
| 2024-05-13 Purchase |
2024-05-14 4:17 pm |
Editas Medicine Inc. | EDIT | Hopfield Jessica Director |
45,000 | $5.6415 | $253,868 | 67,700 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-05 8:00 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
77,824 | $9.4172 | $732,884 | 719,570 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-05 7:54 pm |
Editas Medicine Inc. | EDIT | Mei Baisong SVP, CHIEF MEDICAL OFFICER |
20,327 | $9.4173 | $191,425 | 294,343 (Direct) |
View |
| 2023-12-05 Sale |
2023-12-07 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO |
103 | $10.9 | $1,122 | 74,791 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO |
695 | $8.2096 | $5,706 | 74,894 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-06 Option Award |
2025-06-10 4:19 pm |
N/A 2035-06-05 |
Editas Medicine Inc. | EDIT | Hopfield Jessica Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2025-06-06 Option Award |
2025-06-10 4:19 pm |
N/A 2035-06-05 |
Editas Medicine Inc. | EDIT | Scadden David Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2025-06-06 Option Award |
2025-06-10 4:18 pm |
N/A 2035-06-05 |
Editas Medicine Inc. | EDIT | Levy Elliott M. Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2025-06-06 Option Award |
2025-06-10 4:18 pm |
N/A 2035-06-05 |
Editas Medicine Inc. | EDIT | Connaughton Bernadette Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2025-06-06 Option Award |
2025-06-10 4:18 pm |
N/A 2035-06-05 |
Editas Medicine Inc. | EDIT | Hirsch Andrew Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2025-04-08 Option Award |
2025-04-08 4:29 pm |
N/A 2035-04-07 |
Editas Medicine Inc. | EDIT | Parison Amy SVP, Chief Financial Officer |
34,672 | $0 | 34,672 (Direct) |
View |
Ownership |
2025-04-08 4:20 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Parison Amy SVP, Chief Financial Officer |
0 | $0 | 256,541 (Direct) |
View |
| 2025-03-08 Option Award |
2025-03-27 4:41 pm |
N/A 2035-03-07 |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
345,100 | $0 | 345,100 (Direct) |
View |
| 2025-03-08 Option Award |
2025-03-27 4:37 pm |
N/A 2035-03-07 |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
1,003,000 | $0 | 1,003,000 (Direct) |
View |
| 2025-03-08 Option Award |
2025-03-27 4:33 pm |
N/A 2035-03-07 |
Editas Medicine Inc. | EDIT | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER |
345,100 | $0 | 345,100 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 5:15 pm |
N/A 2034-05-29 |
Editas Medicine Inc. | EDIT | Scadden David Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 5:14 pm |
N/A 2034-05-29 |
Editas Medicine Inc. | EDIT | Hopfield Jessica Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 5:13 pm |
N/A 2034-05-29 |
Editas Medicine Inc. | EDIT | Chatterjee Meeta Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 5:11 pm |
N/A 2034-05-29 |
Editas Medicine Inc. | EDIT | Hirsch Andrew Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:30 pm |
N/A 2034-05-29 |
Editas Medicine Inc. | EDIT | Reeve Emma Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:27 pm |
N/A 2034-05-29 |
Editas Medicine Inc. | EDIT | Levy Elliott M. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:25 pm |
N/A 2034-05-29 |
Editas Medicine Inc. | EDIT | Connaughton Bernadette Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:22 pm |
N/A 2034-05-29 |
Editas Medicine Inc. | EDIT | Vaishnaw Akshay Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-03-02 Option Award |
2024-03-05 8:06 pm |
N/A 2034-03-01 |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
167,266 | $0 | 245,166 (Direct) |
View |
| 2024-03-02 Option Award |
2024-03-05 8:03 pm |
N/A 2034-03-01 |
Editas Medicine Inc. | EDIT | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER |
114,255 | $0 | 159,422 (Direct) |
View |
| 2024-03-02 Option Award |
2024-03-05 8:00 pm |
N/A 2034-03-01 |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
667,225 | $0 | 719,570 (Direct) |
View |
| 2024-03-02 Option Award |
2024-03-05 7:54 pm |
N/A 2034-03-01 |
Editas Medicine Inc. | EDIT | Mei Baisong SVP, CHIEF MEDICAL OFFICER |
242,615 | $0 | 294,343 (Direct) |
View |